Perceptive Advisors’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$47.5M	Buy	10,098,824 +418,639	+4%	+$2.12M	0.94%	27
2025 Q4	$41.2M	Hold	9,680,185	–	–	0.76%	40
2025 Q3	$30.9M	Buy	9,680,185 +2,686,539	+38%	+$6.05M	0.89%	34
2025 Q2	$15.9M	Buy	+6,993,646	New	+$11.3M	0.6%	41
2021 Q3	–	Sell	-1,640,957	Closed	-$10.4M	–	145
2021 Q2	$10.4M	Sell	1,640,957 -513,017	-24%	-$3.99M	0.14%	108
2021 Q1	$16.6M	Sell	2,153,974 -423,069	-16%	-$3.35M	0.22%	84
2020 Q4	$16.9M	Hold	2,577,043	–	–	0.18%	94
2020 Q3	$17.1M	Hold	2,577,043	–	–	0.25%	72
2020 Q2	$21.5M	Sell	2,577,043 -676,880	-21%	-$6.29M	0.35%	57
2020 Q1	$25M	Hold	3,253,923	–	–	0.65%	39
2019 Q4	$27M	Hold	3,253,923	–	–	0.54%	43
2019 Q3	$24M	Buy	3,253,923 +100,000	+3%	+$986K	0.65%	36
2019 Q2	$35.4M	Sell	3,153,923 -20,000	-0.6%	-$210K	0.81%	32
2019 Q1	$34.1M	Buy	3,173,923 +262,208	+9%	+$3.88M	0.96%	30
2018 Q4	$43.6M	Buy	2,911,715 +250,000	+9%	+$3.71M	1.66%	17
2018 Q3	$49.2M	Buy	2,661,715 +740,000	+39%	+$16.9M	1.32%	24
2018 Q2	$43.9M	Sell	1,921,715 -287,097	-13%	-$7.33M	1.15%	28
2018 Q1	$62.8M	Sell	2,208,812 -281,569	-11%	-$8.04M	1.77%	16
2017 Q4	$52.6M	Buy	2,490,381 +1,100,000	+79%	+$22.8M	1.74%	14
2017 Q3	$25.3M	Hold	1,390,381	–	–	0.97%	23
2017 Q2	$21.6M	Sell	1,390,381 -140,278	-9%	-$2.11M	1.12%	28
2017 Q1	$26.4M	Buy	1,530,659 +606,896	+66%	+$7.99M	1.51%	20
2016 Q4	$10.2M	Buy	+923,763	New	+$11.2M	0.72%	34
2016 Q3	–	Sell	-742,021	Closed	-$7.58M	–	200
2016 Q2	$7.58M	Hold	742,021	–	–	0.62%	45
2016 Q1	$9.57M	Buy	742,021 +99,974	+16%	+$1.39M	0.86%	27
2015 Q4	$13.4M	Buy	+642,047	New	+$10.2M	1.03%	27